CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[]
GSH [GUANGSHEN RAILWAY CO] 6-K: THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE
[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred (a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 525) (1) PROPOSED CHANGES IN DIRECTORS (2) PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION; AND (3) NOTICE OF 2015 ANNUAL GENERAL MEETING A notice dated] [(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) Attendance Confirmation Reply Form for the 2015 Annual General Meeting Company AGM Name Number of shares held Identity card number/ passport number Telephone Correspondence Address Notes: (1) Holders of the shares of the Company whose names appear on the registers of members of the Company] [(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) Number of shares to which this proxy form (Note 1) relates Proxy Form for Use by Shareholders at the 2015 Annual General Meeting (Note 2) I/We Company THE CHAIRMAN OF THE MEETING (Note 3) being the shareholder of Guangshen Railway Company Limited (the of] [(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) 2015 ANNUAL RESULT ANNOUNCEMENT Company The Board of Directors of Guangshen Railway Company Limited (the GUANGSHEN RAILWAY 2015 ANNUAL REPORT Chapter 1 Definitions I. DEFINITIONS In this report, unless the context otherwise requires, the expressions stated below will have the following meanings: The Company,] [Number Description of Document 99.1 Proposed Changes in Directors and Proposed Amendment to the Articles of Association; and Notice of the 2015 Annual General Meeting 99.2 Attendance Confirmation Reply Form for the 2015 Annual General Meeting 99.3 Proxy Form for Use by Shareholders at the 2015 Annual General Meeting 99.4 2015 Annual Result Announcement 2 Guangshen Railway Company Limited Dated:]
TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)
[Taiwan Semiconductor Manufacturing Company Ltd. Date : April 14, 2016 By Lora Ho Senior Vice President & Chief Financial Officer TSMC Reports First Quarter EPS of NT$2.50 Hsinchu, Taiwan, R.O.C., April 14, 2016 Year-over-year, first quarter revenue decreased 8.3% while net income and diluted EPS both decreased 18.0%. Compared to fourth quarter 2015, first quarter results represent essentially flat]
BSPM [Biostar Pharmaceuticals] 10-K: (Original Filing)
[FORM 10-K (Mark One) x December 31, 2015 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2015 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated April 14, 2016 relating to the consolidated financial statements, which appears in the Annual Report on Form] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Ronghua Wang Chief Executive Officer EX-32.1 8 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Qinghua Liu Interim Chief Financial Officer EX-32.2 9 ex32-2.htm EX-32.2]
TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: Taiwan Semiconductor Manufacturing Company Ltd. Date : April
[Taiwan Semiconductor Manufacturing Company Ltd. Date : April 14, 2016 By Lora Ho Senior Vice President & Chief Financial Officer TSMC Reports First Quarter EPS of NT$2.50 Hsinchu, Taiwan, R.O.C., April 14, 2016 Year-over-year, first quarter revenue decreased 8.3% while net income and diluted EPS both decreased 18.0%. Compared to fourth quarter 2015, first quarter results represent essentially flat]
BSPM [Biostar Pharmaceuticals] 10-K: FORM 10-K (Mark One) x December 31, 2015
[FORM 10-K (Mark One) x December 31, 2015 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2015 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 14, 2016 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated April 14, 2016 relating to the consolidated financial statements, which appears in the Annual Report on Form] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Ronghua Wang Chief Executive Officer EX-32.1 8 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 14, 2016 Qinghua Liu Interim Chief Financial Officer EX-32.2 9 ex32-2.htm EX-32.2]
JOBS [51JOB] S-8: (Original Filing)
[] [[Maples and Calder letterhead] 51job, Inc. Building 3 No. 1387, Zhang Dong Road Shanghai 201203 People’s Republic of China 14 April 2016 Dear Sirs 51job, Inc. (the "Company") Commission Registration Statement Securities Act Shares Plan Memorandum and Articles Resolutions For the purposes of giving this opinion, we have examined copies of the Registration Statement and the Plan. We have also] [[PricewaterhouseCoopers Zhong Tian LLP letterhead] Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 31, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in 51job, Inc.’s Annual Report on Form 20-F for the]
CNET [ChinaNet Online] 8-K: (Original Filing)
[ChinaNet Online Holdings Reports Fiscal Year 2015 Financial Results 2015 total revenues decreased by 15% YOY to $32.3 million 2015 Gross margin increased to 23.6%, a 42.2% increase YOY 2015 internet advertisement revenues increased to $19.6 million, a 11% increase YOY Full year net loss attributable to ChinaNet decreased by $4.6 million YOY to $9.1 million BEIJING, April 15, 2016] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event Reported): April 14, 2016 ChinaNet Online Holdings, Inc. Nevada 001-34647 20-4672080 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) No. 3 Min Zhuang Road, Building 6, +86-10-6900-5520 [ ] [ ] [ ] [ ] Item 2.02. Results of Operations and Financial Condition. No. Description ChinaNet Online]
JOBS [51JOB] S-8:
[] [[Maples and Calder letterhead] 51job, Inc. Building 3 No. 1387, Zhang Dong Road Shanghai 201203 People’s Republic of China 14 April 2016 Dear Sirs 51job, Inc. (the "Company") Commission Registration Statement Securities Act Shares Plan Memorandum and Articles Resolutions For the purposes of giving this opinion, we have examined copies of the Registration Statement and the Plan. We have also] [[PricewaterhouseCoopers Zhong Tian LLP letterhead] Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 31, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in 51job, Inc.’s Annual Report on Form 20-F for the]
